• Profile
Close

Brodalumab: An evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Core Evidence Aug 17, 2017

Coimbra S, et al. – The potential of brodalumab was explored in the treatment of moderate–to–severe psoriasis. The findings obtained from Phase I and Phase II clinical trials were suggestive of brodalumab being a favorable safety and tolerability profile, with strong clinical activity. This, in turn, indicated that it was a potential instrument for use in the treatment of moderate–to–severe psoriasis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay